France· FR:64252505
OXOMEMAZINE UPSA 0,33 mg/ml SANS SUCRE, solution buvable édulcorée à l'acésulfame potassique
A oxomemazin product containing oxomémazine, registered in France by UPSA.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- OXOMÉMAZINE
- Manufacturer
- UPSA
- Country
- France (FR)
- ATC code
- R06AD08
- ATC class
- Oxomemazin
- Defined daily dose
- 30 mg, O
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009300091301 flacon(s) polytéréphtalate (PET) brun de 125 ml avec gobelet(s) doseur(s) polypropylène
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Oxomemazin in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- Bulgaria · Булзин
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/48e7bc3d-809b-4dd6-acae-c99915f23284 GET /v1/drugs/48e7bc3d-809b-4dd6-acae-c99915f23284?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "64252505",
"date_amm": "2015-03-17",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "OXOMÉMAZINE",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution buvable",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about oxomemazin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.